Intco Medical Technology Co., Ltd. (SHE:300677)
26.78
-0.10 (-0.37%)
Jul 11, 2025, 3:04 PM CST
Intco Medical Technology Revenue
Intco Medical Technology had revenue of 2.49B CNY in the quarter ending March 31, 2025, with 13.20% growth. This brings the company's revenue in the last twelve months to 9.81B, up 30.01% year-over-year. In the year 2024, Intco Medical Technology had annual revenue of 9.52B with 37.65% growth.
Revenue (ttm)
9.81B
Revenue Growth
+30.01%
P/S Ratio
1.74
Revenue / Employee
893.66K
Employees
10,982
Market Cap
17.06B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.52B | 2.60B | 37.65% |
Dec 31, 2023 | 6.92B | 304.91M | 4.61% |
Jan 1, 2023 | 6.61B | -9.63B | -59.27% |
Jan 1, 2022 | 16.24B | 2.40B | 17.37% |
Dec 31, 2020 | 13.84B | 11.75B | 564.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |